ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Inkine Pharmaceutical (MM)

Inkine Pharmaceutical (MM) (INKP)

0.00
0.00
( 0.00% )
更新日時: -

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
-
買値
-
売値
-
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
-
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

INKP 最新ニュース

Inkine Pharmaceutical Announces Approval of Merger with Salix Pharmaceuticals

InKine Pharmaceutical Company, Inc. (Nasdaq: INKP) and Salix Pharmaceuticals, Ltd. (Nasdaq: SLXP) announced that earlier today the shareholders of both companies approved the merger of the two...

Nation's Leading Independent Proxy Advisory Firm Recommends That InKine Shareholders Vote in Favor of Merger with Salix Pharmace

InKine Pharmaceutical Company, Inc. (Nasdaq: INKP) today announced that Institutional Shareholder Services (ISS), the nation's leading independent proxy advisory firm, has recommended that...

InKine Reports Second Quarter 2005 Financial Results

InKine Pharmaceutical Company, Inc. (Nasdaq: INKP): ? Highlights ? -- Entered into a definitive merger agreement with Salix Pharmaceuticals, Ltd. ? -- Filed New Drug Application (NDA) for...

InKine Reports Seven INKP-102 Study Data Abstracts Accepted for Presentation at the Annual Scientific Meeting of the American Co

InKine Pharmaceutical Company, Inc. (Nasdaq: INKP) today announced that seven abstracts with data from clinical studies of the Company's next-generation purgative product, INKP-102, have...

Salix Pharmaceuticals to Acquire InKine Pharmaceutical; Strategic Combination Creates Leading Specialty Pharmaceutical Company F

Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) and InKine Pharmaceutical Company, Inc. (NASDAQ: INKP) announced today that the two companies have entered into a definitive merger agreement under which...

InKine Announces Final Court Approval in Securities Class Action Litigation

InKine Pharmaceutical Company, Inc. (Nasdaq:INKP) today announced that the Philadelphia Court of Common Pleas entered a final judgment order approving the settlement of InKine's class...

InKine Reports First Quarter 2005 Financial Results: Realizing Profitability While Accelerating the Development of INKP-102

InKine Pharmaceutical Company, Inc. (NASDAQ:INKP): -Highlights- ? -- Completed Phase III Clinical Study and Submitted a New Drug Application to FDA for Approval of INKP-102 ? -- Grew...

InKine Announces Submission of a New Drug Application -NDA- for Its Next Generation Purgative Product - INKP-102

InKine Pharmaceutical Company, Inc. (Nasdaq: INKP) today announced that on April 29, 2005 the Company submitted an electronic New Drug Application (NDA) for the United States marketing approval...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
CYCNCyclerion Therapeutics Inc
US$ 7.42
(360.87%)
114.55M
SMXSMX Security Matters Public Company
US$ 0.43
(120.74%)
415.16M
CNEYCN Energy Group Inc
US$ 0.5922
(87.64%)
154.74M
SRMSRM Entertainment Inc
US$ 1.16
(84.10%)
133.35M
HTOOFusion Fuel Green PLC
US$ 0.5701
(79.28%)
265.75M
RLMDRelmada Therapeutics Inc
US$ 0.6396
(-76.91%)
14.41M
MIGIMawson Infrastructure Group Inc
US$ 0.8601
(-54.97%)
10.67M
MONDMondee Holdings Inc
US$ 0.20
(-32.23%)
2.34M
ORISOriental Rise Holdings Ltd
US$ 8.26
(-30.88%)
505.96k
FGLFounder Group Limited
US$ 2.98
(-26.96%)
10.01M
SVMHSRIVARU Holding Ltd
US$ 0.026
(18.18%)
437.28M
SMXSMX Security Matters Public Company
US$ 0.43
(120.74%)
415.16M
HTOOFusion Fuel Green PLC
US$ 0.5701
(79.28%)
265.75M
CNEYCN Energy Group Inc
US$ 0.5922
(87.64%)
154.74M
SRMSRM Entertainment Inc
US$ 1.16
(84.10%)
133.35M

最近閲覧した銘柄

Delayed Upgrade Clock